Lead Product(s) : Undisclosed
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Discovery Platform
Sponsor : Inteligex
Deal Size : Undisclosed
Deal Type : Collaboration
NurExone and Inteligex Begin Research On Chronic Spinal Cord Injury
Details : The collaboration aims to combine Inteligex’s two decades of cell therapy expertise with NurExone’s exosome platform to treat chronic spinal cord injuries.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 17, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Discovery Platform
Sponsor : Inteligex
Deal Size : Undisclosed
Deal Type : Collaboration